A recent property dispute involving a self-represented litigant who relied on AI-generated submissions, including at least one ‘hallucinated’ case, has prompted questions about the need for more active case management of the use of AI by unrepresented parties to prevent wasting court time.
Another solicitor has been reported by a court to the legal watchdog and personally socked with costs for citing non-existent authorities generated by an artificial intelligence program.
After more than a year on ice, two class actions against age care facilities over COVID-19 outbreaks are set to resume late this year, following a month-long criminal trial that kicks off next week.
Mercer Super faces enforcement action by ASIC, alleging the superannuation giant failed to inform the watchdog about investigations into serious issues, including a failure to refund premiums to dead members.
In a major loss for the Australian Taxation Office, a High Court majority has found an agreement between US soft drink giant PepsiCo and Schweppes Australia to sell brands such as Pepsi and Mountain Dew in Australia was not subject to a royalty withholding tax.
The High Court has halved a $40,000 fine received by former Liberal MP Andrew Laming over three Facebook posts that breached electoral rules, finding the penalty should reflect the number of publications rather than the number of views.
The directors of payday lenders Cigno and BSF have filed for special leave to appeal a decision that found them liable for unlicensed credit activity, saying the case raises fundamental questions about the scope of accessorial liability.
The High Court has agree to weigh in on whether an appeals court erred in overturning $200,000 in exemplary damages awarded to each of four children gassed at Don Dale detention centre in the Northern Territory.
CDC Data Centres is planning to open a 200-megawatt data centre in Western Australia, citing heightened demand from AI and the region’s importance for the AUKUS security partnership.
The High Court has rejected Novartis’ plea that it overturn a ruling that found an extension of the term of the patent for its heart drug Entresto was invalidly granted.